UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-life experience of efficacy and safety of bilastine in the refractory cases of chronic spontaneous urticaria and its effect on the quality of life of patients

Indian journal of dermatology, 2021-03, Vol.66 (2), p.159-164

2021

Volltextzugriff (PDF)

Real-World Effectiveness, Safety, and Tolerability of Cetosomal Minoxidil 5% Alone and a Fixed Drug Combination of Cetosomal Minoxidil 5% With Finasteride 0.1% in the Management of Androgenetic Alopecia (Inbilt Study)

Curēus (Palo Alto, CA), 2023-07

2023

Volltextzugriff (PDF)

Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis

Drugs in Context, 2023-01, Vol.12, p.1-11

2023

Volltextzugriff (PDF)

Management of dermatophytosis: Real-world Indian perspective

Indian Dermatology Online Journal, 2023-05, Vol.14 (3), p.347-356

2023

Volltextzugriff (PDF)

A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris

Antibiotics (Basel), 2023-09, Vol.12 (9), p.1455

2023

Volltextzugriff (PDF)

Comparative Clinical Study Evaluating the Efficacy and Safety of Topical 5% Cetosomal Minoxidil and Topical 5% Alcohol-Based Minoxidil Solutions for the Treatment of Androgenetic Alopecia in Indian Men

Curēus (Palo Alto, CA), 2023-10

2023

Volltextzugriff (PDF)

Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea

Indian Dermatology Online Journal, 2023-11, Vol.14 (6), p.839-843

2023

Volltextzugriff (PDF)

Real-world insight on apremilast therapy in patients with plaque psoriasis: Indian experience

Indian journal of dermatology, 2020-09, Vol.65 (5), p.396-400

2020

Volltextzugriff (PDF)

Prospective, Open-Label, Multi-Centre, Randomized Study to Compare the Effectiveness, Safety, and Tolerability of Lulican™ Shampoo Versus Ketoconazole Shampoo in Indian Adult Patients With Mild to Moderate Scalp Seborrheic Dermatitis (LEAD Study)

Curēus (Palo Alto, CA), 2022-11

2022

Volltextzugriff (PDF)

Intermittent or Sequential Topical Tacrolimus in Atopic Dermatitis: Systematic Review and Meta-Analysis

Curēus (Palo Alto, CA), 2023-12

2023

Volltextzugriff (PDF)

Apremilast Titration: Real-World Indian Experience

Clinical Dermatology Review, 2021-07, Vol.5 (2), p.183-186

2021

Volltextzugriff (PDF)

Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic

Indian journal of dermatology, 2019-05, Vol.64 (3), p.239-241

2019

Volltextzugriff (PDF)

Apremilast generic for the treatment of active psoriatic arthritis: A single-center real-life experience from India

Indian journal of rheumatology, 2020-01, Vol.15 (1), p.46-48

2020

Volltextzugriff (PDF)

The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study

Curēus (Palo Alto, CA), 2023-04

2023

Volltextzugriff (PDF)

Comparative Clinical Assessment of Updosing of Bilastine and Combination of Levocetirizine and Hydroxyzine in Chronic Spontaneous Urticaria

Clinical Dermatology Review, 2022-01, Vol.6 (1), p.28-31

2022

Volltextzugriff (PDF)

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis

Indian journal of dermatology, 2017-07, Vol.62 (4), p.395-399

2017

Volltextzugriff (PDF)

26572 Effect of bilastine on chronic spontaneous urticaria (CSU) refractory to fexofenadine: Real world experience from India

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB106-AB106

2021

Volltextzugriff (PDF)

Comparative real-world effectiveness and safety of super-bioavailable itraconazole 50 mg bd and 65 mg bd in the management of dermatophytosis

International Journal of Research in Dermatology, 2022-06, Vol.8 (4), p.433

2022

Volltextzugriff (PDF)

A real-world, non-interventional Indian study on clinical assessment of intense moisturizing formulation in dry skin disorders

International Journal of Research in Dermatology, 2021-10, Vol.7 (6), p.848

2021

Volltextzugriff (PDF)

Comparative analysis of serum and sebum concentration of super-bioavailable itraconazole 50 versus 65 mg in healthy adult volunteers

International Journal of Research in Dermatology, 2022-12, Vol.9 (1), p.59

2022

Volltextzugriff (PDF)

Real-World Indian Experience of Switchover to Bilastine 40 mg/day in CSU Patient Refractory to Other Antihistamines at Double Dose

Indian journal of dermatology, 2023-11, Vol.68 (6), p.674-677

2023

Volltextzugriff (PDF)

An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India

Clinical, cosmetic and investigational dermatology, 2021-01, Vol.14, p.1367-1376

2021

Volltextzugriff (PDF)

Comparative real world clinical assessment of fixed dose combination of mometasone and fusidic acid cream versus fluticasone and mupirocin ointment in the management of atopic dermatitis with secondary bacterial infection

International Journal of Research in Dermatology, 2022-08, Vol.8 (5), p.453

2022

Volltextzugriff (PDF)

Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique

Dermatology (Basel), 2024-08, Vol.240 (4), p.671-683

2024

Volltextzugriff (PDF)

Clinical assessment of Super bioavailable Itraconazole 50 mg in dermatophytosis (Clear 50)

IP Indian Journal of Clinical and Experimental Dermatology, 2021-05, Vol.7 (2), p.125-129

2021

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(68)
Berichte
(1)

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real-life experience of efficacy and safety of bilastine in the refractory cases of chronic spontaneous urticaria and its effect on the quality of life of patients

Real-World Effectiveness, Safety, and Tolerability of Cetosomal Minoxidil 5% Alone and a Fixed Drug Combination of Cetosomal Minoxidil 5% With Finasteride 0.1% in the Management of Androgenetic Alopecia (Inbilt Study)

Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis

Management of dermatophytosis: Real-world Indian perspective

A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris

Comparative Clinical Study Evaluating the Efficacy and Safety of Topical 5% Cetosomal Minoxidil and Topical 5% Alcohol-Based Minoxidil Solutions for the Treatment of Androgenetic Alopecia in Indian Men

Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea

Real-world insight on apremilast therapy in patients with plaque psoriasis: Indian experience

Prospective, Open-Label, Multi-Centre, Randomized Study to Compare the Effectiveness, Safety, and Tolerability of Lulican™ Shampoo Versus Ketoconazole Shampoo in Indian Adult Patients With Mild to Moderate Scalp Seborrheic Dermatitis (LEAD Study)

Intermittent or Sequential Topical Tacrolimus in Atopic Dermatitis: Systematic Review and Meta-Analysis

Apremilast Titration: Real-World Indian Experience

Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic

Apremilast generic for the treatment of active psoriatic arthritis: A single-center real-life experience from India

The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study

Comparative Clinical Assessment of Updosing of Bilastine and Combination of Levocetirizine and Hydroxyzine in Chronic Spontaneous Urticaria

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis

26572 Effect of bilastine on chronic spontaneous urticaria (CSU) refractory to fexofenadine: Real world experience from India

Comparative real-world effectiveness and safety of super-bioavailable itraconazole 50 mg bd and 65 mg bd in the management of dermatophytosis

A real-world, non-interventional Indian study on clinical assessment of intense moisturizing formulation in dry skin disorders

Comparative analysis of serum and sebum concentration of super-bioavailable itraconazole 50 versus 65 mg in healthy adult volunteers

Real-World Indian Experience of Switchover to Bilastine 40 mg/day in CSU Patient Refractory to Other Antihistamines at Double Dose

An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India

Comparative real world clinical assessment of fixed dose combination of mometasone and fusidic acid cream versus fluticasone and mupirocin ointment in the management of atopic dermatitis with secondary bacterial infection

Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique

Clinical assessment of Super bioavailable Itraconazole 50 mg in dermatophytosis (Clear 50)

Suchergebnisse filtern